ArticleKorean journal of ophthalmology : KJO2024
Repeatability of Corneal Epithelial Thickness Map Using Anterior-Segment Optical Coherence Tomography in Normal and Corneal Disease Patients.
Article in Korean journal of ophthalmology : KJO, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the repeatability of corneal epithelial thickness (CET) measurements in normal eyes and eyes diagnosed with corneal disease using the epithelial thickness map (ETM) of anterior-segment optical coherence tomography (OCT).
methodsIn this retrospective study, patients with three OCT scans using the ETM mode of Cirrus OCT between October 2021 and January 2024 were reviewed. Two groups of subjects were included: (1) normal subjects with no history of ophthalmic surgery, corneal diseases, and topical antiglaucoma medication uses; and (2) subjects with corneal diseases including dry eye syndrome, recurrent corneal erosion, pterygium, and others. A total of 57 eyes of 57 normal subjects and 106 eyes of 76 patients with corneal disease were included. ETM was analyzed in 25 zones (one zone within 0-2 mm diameter, eight zones within 2-5 mm diameter, eight zones within 5-7 mm diameter, and eight zones within 7-9 mm diameter). Repeatability was evaluated by calculating intraclass correlation coefficient (ICC), coefficient of variation (CoV), within-subject standard deviation (Sw), and Bland-Altman plot.
resultsAmong a total of 25 sectors, the normal eyes showed high repeatability (ICC, >0.75; CoV, 2.160%-5.292%; Sw, 0.760- 1.653 μm) in 23 sectors, and corneal diseases patients also showed high repeatability (ICC, >0.75; CoV, 4.167%-9.606%; Sw, 1.298-3.340 μm) in 22 sectors. However, the wide range of 95% limit of agreement width of Bland-Altman plot presented in corneal disease group and some peripheral zones in normal eyes indicates some variability of CET measurements.
conclusionsExcept for a few peripheral sectors, ETM of Cirrus OCT provides repeatable CET measurements in normal eyes; however in corneal disease group, repeatability was not consistently high. To measure CET accurately, performing multiple measurements is advised especially in patients with corneal disease and patients in whom peripheral CET values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.